AFRAXIS INC has a total of 45 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and computer technology are AFRAXIS HOLDINGS INC, AGENEBIO INC and ADERIS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 20 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | China | 4 | |
#5 | Argentina | 3 | |
#6 | Taiwan | 3 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Duron Sergio G | 39 |
#2 | Campbell David | 37 |
#3 | Vollrath Benedikt | 27 |
#4 | Wade Warren | 15 |
#5 | Lichter Jay | 10 |
#6 | David Campbell | 3 |
#7 | Behnke Mark | 2 |
#8 | Boikess Steven Ray | 2 |
#9 | Warren Wade | 2 |
#10 | Rex Christopher Steven | 2 |
Publication | Filing date | Title |
---|---|---|
US8977024B1 | Distributed anatomical image analysis | |
WO2011156786A2 | 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders | |
WO2011156640A2 | 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | |
EP2519241A2 | Methods for treating autism | |
EP2504011A2 | Methods for treating mild cognitive impairment | |
WO2011044535A2 | 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders | |
EP2485727A2 | Pyrrolopyrazoles for treating cns disorders | |
WO2010071846A2 | Compounds for treating neuropsychiatric conditions | |
WO2009086204A2 | Methods for treating neuropsychiatric conditions | |
WO2009086202A2 | Methods for treating neuropsychiatric conditions |